EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia

Jovana Joksimovic iD, Dusan Mihajlo Spasic iD, Marija Kukuric, Milica Bajcetic

Children · 12.04.2026 · 13 (4) · 536

DOI: 10.3390/children13040536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 12.04.2026. Verfasst von Jovana Joksimovic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Human Medicines Centre, Medicines and Medical Devices Agency of Serbia (ALIMS), 11221 Belgrade, Serbia. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Adverse drug reactions are associated with off-label (OL) and unlicensed (UL) drug use in children.

Methods

We conducted a retrospective observational pharmacovigilance study based on individual case safety reports (ICSRs) and adverse drug reactions (ADRs) from VigiBase for patients aged 0–17 years to evaluate reporting patterns associated with off-label and unlicensed suspected drugs reported in Serbia.

Results

Over 14 years, 2037 pediatric ICSRs comprising 4257 ADRs were reported. Infants (28 days–23 months) accounted for just over half of ICSRs, and systemic anti-infectives and vaccines dominated suspected drugs. Overall, 9.7% of ADRs were serious, including 12 fatal outcomes, with serious ADRs reported more often for non-vaccine than vaccine suspected drugs. Off-label and unlicensed suspected drug records accounted for 10.8% and 1.9% of suspected drug records, respectively, and had higher proportions of serious ADRs than on-label or licensed use (off-label 12.1% vs. on-label 9.4%, p = 0.04; unlicensed 22.9% vs. licensed 9.4%, p < 0.001). In the adjusted ICSR-level logistic regression, neonatal age was the strongest independent predictor of seriousness, with approximately threefold higher odds of a serious case compared with children (aOR 3.04, 95% CI 1.55–5.98).

Conclusions

Although off-label and unlicensed drugs accounted for a minority of pediatric reports, they were associated with a higher proportion of serious reported ADRs, particularly in the neonatal period. These findings should be interpreted as pharmacovigilance reporting patterns rather than incidence-based estimates or proof of causality.

Schlagwörter

Stichwörter der Autor:innen

VigiBaseadverse drug reactionsoff-label usepediatricunlicensed drug

Autor:innen und Institutionen

  • Human Medicines Centre, Medicines and Medical Devices Agency of Serbia (ALIMS), 11221 Belgrade, Serbia.
  • Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Department of Emergency Radiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.

ORCID-Profile: Jovana Joksimovic, Dusan Mihajlo Spasic

Zitieren

APA

Joksimovic, J., Spasic, D. M., Kukuric, M., & Bajcetic, M. (2026). Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia. Children, 13(4), 536. https://doi.org/10.3390/children13040536

Vancouver

Joksimovic J, Spasic DM, Kukuric M, Bajcetic M. Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia. Children. 2026;13(4):536. doi:10.3390/children13040536

BibTeX
@article{Joksimovic2026,
  author = {Joksimovic, Jovana and Spasic, Dusan Mihajlo and Kukuric, Marija and Bajcetic, Milica},
  title = {Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {4},
  pages = {536},
  doi = {10.3390/children13040536}
}
Kostenlos starten →